Literature DB >> 26151616

Usefulness of the ratio of orbital fat to total orbit area in mild-to-moderate thyroid-associated ophthalmopathy.

H C Kim1, S W Yoon2, H Lew1.   

Abstract

OBJECTIVE: To identify a useful predictor of thyroid-associated ophthalmopathy (TAO) from orbital CT images; to evaluate the orbital fat and extraocular muscle area ratio as a CT-derived measure; and to investigate the correlations between this ratio and the clinical manifestations in mild-to-moderate TAO.
METHODS: Between January 2012 and March 2013, 44 patients with TAO and 23 controls were studied prospectively. All of the patients underwent ophthalmic examinations, including clinical activity score, exophthalmometry, clinical photographs, alternate prism and cover test, duction and version test, Hess screen test, binocular single vision test, thyroid function tests and orbital CT. The cross-sectional areas of the four rectus muscles, superior oblique muscle, optic nerve and total orbit area were calculated in the coronal view 6 mm posterior from the posterior pole of globe.
RESULTS: The cross-sectional area measured on orbital CT showed increased orbital fat in patients with TAO and an increased orbital fat to total orbit area ratio (fat/orbit) in TAO with retraction and proptosis. There were significant correlations between fat/orbit and margin reflex distance 1 (p = 0.022), margin reflex distance 2 (p = 0.013) and the exophthalmometric value (p = 0.007).
CONCLUSION: The orbital fat to total orbit area ratio (fat/orbit) is a useful diagnostic index in mild-to-moderate TAO. ADVANCES IN KNOWLEDGE: The orbital CT offers a useful diagnostic index in TAO.

Entities:  

Mesh:

Year:  2015        PMID: 26151616      PMCID: PMC4743576          DOI: 10.1259/bjr.20150164

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  15 in total

Review 1.  Graves' disease.

Authors:  A P Weetman
Journal:  N Engl J Med       Date:  2000-10-26       Impact factor: 91.245

2.  Graves' ophthalmopathy: eye muscle involvement in patients with diplopia.

Authors:  E V Nagy; J Toth; I Kaldi; J Damjanovich; E Mezosi; A Lenkey; L Toth; J Szabo; Z Karanyi; A Leovey
Journal:  Eur J Endocrinol       Date:  2000-06       Impact factor: 6.664

Review 3.  Pathogenesis of Graves' ophthalmopathy.

Authors:  R S Bahn; A E Heufelder
Journal:  N Engl J Med       Date:  1993-11-11       Impact factor: 91.245

4.  Clinical classification of Graves' ophthalmopathy. Identification of risk factors for optic neuropathy.

Authors:  S E Feldon; S Muramatsu; J M Weiner
Journal:  Arch Ophthalmol       Date:  1984-10

5.  Quantitative computed tomography of Graves' ophthalmopathy. Extraocular muscle and orbital fat in development of optic neuropathy.

Authors:  S E Feldon; C P Lee; S K Muramatsu; J M Weiner
Journal:  Arch Ophthalmol       Date:  1985-02

Review 6.  Management of Graves' ophthalmopathy: reality and perspectives.

Authors:  L Bartalena; A Pinchera; C Marcocci
Journal:  Endocr Rev       Date:  2000-04       Impact factor: 19.871

7.  Eye muscle antibodies and subtype of thyroid-associated ophthalmopathy.

Authors:  Matthias Kaspar; Curtis Archibald; Bellis Anna Maria De; Audrey Wu Li; Masayo Yamada; Cheng-Hsien Chang; George Kahaly; Jack Ronald Wall
Journal:  Thyroid       Date:  2002-03       Impact factor: 6.568

8.  CT scan evidence of dysthyroid optic neuropathy.

Authors:  JoAnn A Giaconi; Michael Kazim; Tae Rho; Charles Pfaff
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2002-05       Impact factor: 1.746

9.  Long-term efficacy of orbital decompression for compressive optic neuropathy of Graves' eye disease.

Authors:  K D Carter; B R Frueh; T P Hessburg; D C Musch
Journal:  Ophthalmology       Date:  1991-09       Impact factor: 12.079

10.  Dysthyroid optic neuropathy without extraocular muscle involvement.

Authors:  R L Anderson; J P Tweeten; J R Patrinely; P E Garland; S M Thiese
Journal:  Ophthalmic Surg       Date:  1989-08
View more
  4 in total

1.  [Calculation of orbital fat volumes for determining treatment timing for thyroid- associated ophthalmopathy].

Authors:  Wei Jiang; Qiu-Yue Cai; Zhang-Fang Li; Zhi-Yi Chen; Yao-Sheng Luo; Shi-di Hu; Jie Shen
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-05-20

2.  [A novel method for quantitative measurement of orbital fat volume based on magnetic resonance images].

Authors:  Qiu-Yue Cai; Zhi-Yi Chen; Wei Jiang; Yao-Sheng Luo; Zhang-Fang Li; Shi-di Hu; Jie Shen
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-09-20

3.  Pingmu Decoction Induces Orbital Preadipocytes Apoptosis In Vitro.

Authors:  Yali Zhang; Hong Li; Long Gao; Xia Zhang; RuiFang Xie
Journal:  Evid Based Complement Alternat Med       Date:  2017-04-18       Impact factor: 2.629

4.  Current insights of applying MRI in Graves' ophthalmopathy.

Authors:  Cheng Song; Yaosheng Luo; Genfeng Yu; Haixiong Chen; Jie Shen
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-29       Impact factor: 6.055

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.